The Alpha Synuclein Market has experienced remarkable growth in recent years, driven by increasing recognition of alpha-synuclein as a central pathological hallmark of Parkinson's disease and related synucleinopathies. This neuronal protein, when misfolded and aggregated into Lewy bodies, drives neurodegeneration and progressive motor and cognitive decline. Researchers, diagnostic developers,...